<li>benazepril<p>benazepril, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>captopril<p>captopril, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>enalapril<p>enalapril, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>everolimus<p>everolimus, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>fosinopril<p>fosinopril, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>imidapril<p>imidapril, pregabalin.
Either increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Additive risk of developing angioedema of face, mouth, and neck, including respiratory compromise.</p></li><li>lisinopril<p>lisinopril, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>moexipril<p>moexipril, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>perindopril<p>perindopril, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>quinapril<p>quinapril, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>ramipril<p>ramipril, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>sirolimus<p>sirolimus, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>temsirolimus<p>temsirolimus, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li><li>trandolapril<p>trandolapril, pregabalin.
Either increases toxicity of the other by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Coadministration results in additive risk of developing angioedema of face, mouth, and neck. Angioedema may result in respiratory compromise.</p></li>